Cargando…

Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying TNNI3 mutations

Hypertrophic cardiomyopathy (HCM) is a common inherited heart disease with a prevalence of about 0.2%. HCM is typically caused by mutations in genes encoding sarcomere or sarcomere-associated proteins. Here, we characterized induced pluripotent stem cell (iPSC) lines generated from the peripheral bl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Shane Rui, Shen, Mengcheng, Lee, Chelsea, Zha, Yanjun, Guevara, Julio V., Wheeler, Matthew T., Wu, Joseph C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095754/ https://www.ncbi.nlm.nih.gov/pubmed/34798544 http://dx.doi.org/10.1016/j.scr.2021.102597

Ejemplares similares

Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYH7 mutations
por: Cao, Xu, et al.
Publicado: (2021)

Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying TTN mutations
por: Zhang, Tina Tianbo, et al.
Publicado: (2022)

Tnni3k Modifies Disease Progression in Murine Models of Cardiomyopathy
por: Wheeler, Ferrin C., et al.
Publicado: (2009)

Genetic Studies of Hypertrophic Cardiomyopathy in Singaporeans Identify Variants in TNNI3 and TNNT2 That Are Common in Chinese Patients
por: Pua, Chee Jian, et al.
Publicado: (2020)

TNNI3 and KCNQ1 co-inherited variants in a family with hypertrophic cardiomyopathy and long QT phenotypes: A case report
por: Cava, Francesco, et al.
Publicado: (2021)

Generation of three iPSC lines from dilated cardiomyopathy patients carrying a pathogenic LMNA variant
por: Lee, Chelsea, et al.
Publicado: (2022)

Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy
por: van den Wijngaard, A., et al.
Publicado: (2011)

High prevalence of Arginine to Glutamine Substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians
por: Rani, Deepa Selvi, et al.
Publicado: (2012)

Pediatric restrictive cardiomyopathy due to a heterozygous mutation of the TNNI3 gene
por: Chen, Yan, et al.
Publicado: (2014)

Generation of two iPSC lines from hypertrophic cardiomyopathy patients carrying MYBPC3 and PRKAG2 variants
por: Manhas, Amit, et al.
Publicado: (2022)

Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients
por: Caudal, Arianne, et al.
Publicado: (2022)

Genetic Burden of TNNI3K in Diagnostic Testing of Patients With Dilated Cardiomyopathy and Supraventricular Arrhythmias
por: Pham, Caroline, et al.
Publicado: (2023)

A Novel TNNI3 Gene Mutation (c.235C>T/ p.Arg79Cys) Found in a Thirty-eight-year-old Women with Hypertrophic Cardiomyopathy
por: Tao, Qin, et al.
Publicado: (2018)

Diverse Phenotypic Expression of Cardiomyopathies in a Family with TNNI3 p.Arg145Trp Mutation
por: Hwang, Ji-won, et al.
Publicado: (2017)

Homozygous TNNI3 Mutations and Severe Early Onset Dilated Cardiomyopathy: Patient Report and Review of the Literature
por: Sorrentino, Ugo, et al.
Publicado: (2023)

Generation of two induced pluripotent stem cell lines carrying the phospholamban R14del mutation for modeling ARVD/C
por: Vera, Carlos D., et al.
Publicado: (2022)

Protocol to generate cardiac pericytes from human induced pluripotent stem cells
por: Shen, Mengcheng, et al.
Publicado: (2023)

TNNI1 Mutated in Autosomal Dominant Proximal Arthrogryposis
por: Nishimori, Yukako, et al.
Publicado: (2021)

Generation of two heterozygous MYBPC3 mutation-carrying human iPSC lines, SCVIi001-A and SCVIi002-A, for modeling hypertrophic cardiomyopathy
por: Liu, Lichao, et al.
Publicado: (2021)

A case report of recessive restrictive cardiomyopathy caused by a novel mutation in cardiac troponin I (TNNI3)
por: Pantou, Malena P., et al.
Publicado: (2019)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells
por: Han, Lu, et al.
Publicado: (2014)

Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Enables Modeling of Human Hypertrophic Cardiomyopathy
por: Knight, Walter E., et al.
Publicado: (2021)

Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells
por: Li, Jiangtao, et al.
Publicado: (2022)

Whole-Exome Sequencing Identifies a Novel Variant (c.1538T > C) of TNNI3K in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Xie, Ting, et al.
Publicado: (2022)

Distal arthrogryposis with variable clinical expression caused by TNNI2 mutation
por: Čulić, Vida, et al.
Publicado: (2016)

The Diverse Roles of TNNI3K in Cardiac Disease and Potential for Treatment
por: Pham, Caroline, et al.
Publicado: (2021)

What Causes Hypertrophic Cardiomyopathy?
por: Maron, Bradley A., et al.
Publicado: (2022)

Generation of two iPSC lines from long QT syndrome patients carrying SNTA1 variants
por: Jimenez-Tellez, Nerea, et al.
Publicado: (2023)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

TNNI3K is a novel mediator of myofilament function and phosphorylates cardiac troponin I
por: Wang, Hui, et al.
Publicado: (2013)

HIRA Is Required for Heart Development and Directly Regulates Tnni2 and Tnnt3
por: Dilg, Daniel, et al.
Publicado: (2016)

Tnni3k alleles influence ventricular mononuclear diploid cardiomyocyte frequency
por: Gan, Peiheng, et al.
Publicado: (2019)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019)

Altered force generation and cell-to-cell contractile imbalance in hypertrophic cardiomyopathy
por: Kraft, Theresia, et al.
Publicado: (2019)

Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
por: Puckelwartz, Megan J., et al.
Publicado: (2021)

Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations
por: Spudich, James A.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ajifu3b9n5bmsujof73fudlbm1